BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers

InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug r...

May 09, 2022 | News

Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials

The new funding, involving Icehouse Ventures, The Development Bank of Wales, Parkwalk Advisors, British Growth Fund and a consortium of Angel investors, wi...

May 05, 2022 | News

Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials

The new funding, involving Icehouse Ventures, The Development Bank of Wales, Parkwalk Advisors, Business Growth Fund and a consortium of Angel investors, w...

May 02, 2022 | News

Avantor® Reports First Quarter 2022 Results

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologi...

April 29, 2022 | News

Samsung Biologics Reports First Quarter 2022 Financial Results

Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, today announced strong financial results for t...

April 28, 2022 | News

GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn

Sierra Oncology’s differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia ...

April 14, 2022 | News

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative

HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy by investing ...

April 13, 2022 | News

Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative

Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced expansion of their open collaboration strategy by inves...

April 12, 2022 | News

Mindtree Invests in COPE Health Solutions to Accelerate its Healthcare Business

Based in Los Angeles and New York, COPE Health Solutions works with health systems, health plans, medical groups, and other healthcare organ...

April 06, 2022 | News

RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines

The Company intends to use the funding to accelerate its research and development of mRNA vaccine and drug discovery focused on infectious disease, cancer,...

March 30, 2022 | News

Samsung Biologics holds 11th Annual General Meeting of Shareholders

Five matters were presented and approved unanimously at this year's meeting, which included the approval of financial statement, appointment of directors, ...

March 29, 2022 | News

Genscript Biotech Reports 2021 Annual Results

Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, representing an increase of 30.8% as compare...

March 21, 2022 | News

Eppendorf invests in Swiss startup BigOmics

“We’re excited to invest in BigOmics,” said Peter Fruhstorfer, Co-CEO of Eppendorf SE, upon signing the agreement. “With its expert...

March 15, 2022 | News

MediLink Therapeutics closes US$70 million Series B financing

The new funding will support clinical development of MediLink's new generation Antibody-Drug Conjugate (ADC) pipeline, as well as early discovery and devel...

March 15, 2022 | News

Stay Connected